Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

EFGARTIGIMOD ALFA for Pemphigus: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 9 adverse event reports in the FDA FAERS database where EFGARTIGIMOD ALFA was used for Pemphigus.

Most Reported Side Effects for EFGARTIGIMOD ALFA

Side Effect Reports % Deaths Hosp.
Myasthenia gravis 46 18.5% 2 30
Off label use 39 15.7% 1 13
Drug ineffective 25 10.0% 3 16
Myasthenia gravis crisis 25 10.0% 0 16
Fatigue 22 8.8% 0 6
Pneumonia 20 8.0% 6 17
Muscular weakness 17 6.8% 0 4
Urinary tract infection 17 6.8% 2 6
Malaise 14 5.6% 3 7
Covid-19 13 5.2% 1 10
Dyspnoea 13 5.2% 1 5
Headache 13 5.2% 0 2
Therapeutic product effect incomplete 12 4.8% 0 7
Therapy non-responder 12 4.8% 1 8
Symptom recurrence 11 4.4% 1 4

Other Indications for EFGARTIGIMOD ALFA

Myasthenia gravis (170) Immune thrombocytopenia (25) Product used for unknown indication (16) Chronic inflammatory demyelinating polyradiculoneuropathy (8) Muscular weakness (7)

Other Drugs Used for Pemphigus

RITUXIMAB (1,331) PREDNISONE (831) MYCOPHENOLATE MOFETIL (539) PREDNISOLONE (360) AZATHIOPRINE (325) METHYLPREDNISOLONE (181) HUMAN IMMUNOGLOBULIN G (135) METHOTREXATE (107) CYCLOPHOSPHAMIDE (68) RITUXIMAB-ABBS (67)

Related Pages

EFGARTIGIMOD ALFA Full Profile All Pemphigus Drugs EFGARTIGIMOD ALFA Demographics EFGARTIGIMOD ALFA Timeline